This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Jenny Mattsson
Principal Scientist at BioInvent International AB


Jenny Mattsson has 20+ years of experience in antibody discovery. She currently holds a position as Principal Scientist in the Preclinical Research department at BioInvent, Lund, Sweden. As a senior member of the team, Jenny has coordinated discovery efforts in several antibody drug projects, currently in preclinical or clinical development, and she was a key person in building the phenotypic antibody-target discovery platform F.I.R.S.TTM.

Agenda Sessions

  • Sequence Enrichment Profiles Enable tTarget-agnostic Antibody Generation for a Broad Range of Antigens